Chronic Thromboembolic Pulmonary Hypertension: Experience from a Single Center in Mexico
- PMID: 26748498
- PMCID: PMC5523124
- DOI: 10.1007/s00408-016-9842-y
Chronic Thromboembolic Pulmonary Hypertension: Experience from a Single Center in Mexico
Abstract
Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by precapillary pulmonary hypertension secondary to vaso-occlusive pulmonary vasculopathy and is classified as Pulmonary Hypertension Group 4. The aim of this study is to report the clinical experience of CTEPH in Mexico.
Methods: Consecutive patients diagnosed with CTEPH were identified from the Registro de Pacientes con Hipertension Pulmonar del Instituto de Seguridad y Servicio Social de los Trabajadores del Estado (REPHPISSSTE) registry between January 2009 and February 2014. Right heart catheterization was not routinely performed prior to August 2010 in the work-up of CTEPH.
Results: We identified 50 patients with CTEPH; their median age was 63 years and 58 % were female. Patients had multiple associated co-morbidities and moderate hemodynamic impairment. All patients were treated with anticoagulation. Despite surgical evaluation for pulmonary endarterectomy (PEA), only one patient underwent PEA given the lack of infrastructure for post-operative care and lack of insurance for this procedure. Most of the patients were treated with sildenafil, bosentan, or both, with increasing use of rivaroxaban and sildenafil in recent years. The overall survival of the cohort was similar to that reported in other international registries, despite the limitations of care imposed by drug availability and surgical feasibility.
Conclusion: This is the first report on the CTEPH experience in Mexico. It highlights the similarity of patients in the REPHPISSSTE registry to those in international registries as well as the challenges that clinicians face in a resource-limited setting.
Keywords: Chronic thromboembolic pulmonary hypertension; Management; Pulmonary endarterectomy; Survival.
Conflict of interest statement
Figures
Similar articles
-
Update on chronic thromboembolic pulmonary hypertension.Trends Cardiovasc Med. 2017 Jan;27(1):29-37. doi: 10.1016/j.tcm.2016.05.010. Epub 2016 May 25. Trends Cardiovasc Med. 2017. PMID: 27345156 Review.
-
Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature.J Cardiovasc Med (Hagerstown). 2019 Apr;20(4):159-168. doi: 10.2459/JCM.0000000000000774. J Cardiovasc Med (Hagerstown). 2019. PMID: 30720636 Review.
-
Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy.J Am Heart Assoc. 2015 Mar 23;4(3):e001602. doi: 10.1161/JAHA.114.001602. J Am Heart Assoc. 2015. PMID: 25801760 Free PMC article.
-
Long-term outcomes of surgery for chronic thromboembolic pulmonary hypertension compared with medical therapy at a single Korean center.Korean J Intern Med. 2017 Sep;32(5):855-864. doi: 10.3904/kjim.2016.049. Epub 2016 Oct 13. Korean J Intern Med. 2017. PMID: 27733022 Free PMC article.
-
Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism.J Thromb Haemost. 2018 Jun;16(6):1040-1051. doi: 10.1111/jth.14016. Epub 2018 May 8. J Thromb Haemost. 2018. PMID: 29608809 Review.
Cited by
-
Research progress on the pathogenesis of CTEPH.Heart Fail Rev. 2019 Nov;24(6):1031-1040. doi: 10.1007/s10741-019-09802-4. Heart Fail Rev. 2019. PMID: 31087212 Review.
-
Comorbidity Burden in Chronic Thromboembolic Pulmonary Hypertension: Implications and Outcome.Medicina (Kaunas). 2025 Apr 30;61(5):827. doi: 10.3390/medicina61050827. Medicina (Kaunas). 2025. PMID: 40428788 Free PMC article.
-
Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension.Int J Chron Obstruct Pulmon Dis. 2018 Jan 26;13:385-397. doi: 10.2147/COPD.S152971. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29416329 Free PMC article.
-
Changed hemodynamics in acute vasoreactivity testing: prognostic predictors in chronic thromboembolic pulmonary hypertension.Am J Transl Res. 2020 Mar 15;12(3):959-973. eCollection 2020. Am J Transl Res. 2020. PMID: 32269727 Free PMC article.
-
Chronic Thromboembolic Pulmonary Hypertension: A Worldwide View of How Far We Have Come.Lung. 2016 Jun;194(3):483-5. doi: 10.1007/s00408-016-9863-6. Epub 2016 Feb 29. Lung. 2016. PMID: 26926873 No abstract available.
References
-
- Auger WR, Kim NH, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. Clin Chest Med. 2007;28:255–269x. - PubMed
-
- Lang IM, Pesavento R, Bonderman D, et al. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41:462–468. - PubMed
-
- Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation. 2014;130:508–518. - PubMed
-
- Riedel M, Stanek V, Widimsky J, et al. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982;81:151–158. - PubMed
-
- Bonderman D, Wilkens H, Wakounig S, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33:325–331. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical